TNFRSF9 and breast cancer: Cryoablation triggers immune activation in early BC, as indicated by increased CD137+ T cells, reduced Tregs, elevated HMGB1, enhanced inflammatory cytokine release, and the presence of mild to intense inflammatory infiltrates in surgical samples.